News Releases

LivTech and Yakult Honsha Enter into Option Agreement for LIV-2008,LivTech’s Anti-Cancer Monoclonal Antibodies Program

November 2011

News Release

  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • For Investors

Get ADOBE® READER®

You need Adobe Reader to view PDF documents.